Subscribe Us

header ads

Recents

header ads

Topical Drug Delivery Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - January 25, 2023

According to the research report, the global topical drug delivery market size is expected to touch USD 172.54 Billion by 2030, from USD 102.42 Billion in 2022, growing with a significant CAGR of 6.7% from 2022 to 2030. 


Topical Drug Delivery Market Size 2022 to 2030

The topical drug delivery report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global topical drug delivery in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global topical drug delivery market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global topical drug delivery during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1561

 Report Scope of the Topical Drug Delivery Market

Report CoverageDetails
Market SizeUSD 172.54 Billion by 2030
Growth RateCAGR of 6.7 % from 2022 to 2030
Base Year2021
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Forecast Period2022 to 2030
Segments CoveredRoute of Administration, Application, Region

This study covers a detailed segmentation of the global topical drug delivery market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global topical drug delivery market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Johnson & Johnson
  • Novartis International AG
  • F. Hoffmann-La Roche AG
  • Pfizer Inc.
  • Bayer AG
  • Antares Pharma, Inc.
  • GlaxoSmithKline plc
  • 3M (US), Merck & Co., Inc.
  • Sanofi
  • Amgen, Inc.

Market Segmentation

 By Product

  • Semi-Solid Formulations
    • Creams
    • Ointments
    • Lotions
    • Gels
    • Pastes
  • Liquid Formulations
    • Solutions
    • Suspensions
  • Solid Formulations
    • Powders
    • Suppositories
  • Transdermal Products
    • Transdermal Patches
    • Transdermal Semi-solids

By Route of Administration

  • Oral
  • Injectable
  • Topical
  • Ocular
  • Pulmonary
  • Implantable
  • Transmucosal
  • Nasal

By Application

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Other Applications

By End User

  • Home Care Settings
  • Hospitals & Clinics
  • Burn Centers
  • Other Facilities

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global topical drug delivery report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global topical drug delivery market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Topical Drug Delivery Market 

5.1. COVID-19 Landscape: Topical Drug Delivery Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Topical Drug Delivery Market, By Product

8.1. Topical Drug Delivery Market, by Product Type, 2021-2030

8.1.1. Semi-Solid Formulations

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Liquid Formulations

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Solid Formulations

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Transdermal Products

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Topical Drug Delivery Market, By Route of Administration

9.1. Topical Drug Delivery Market, by Route of Administration, 2021-2030

9.1.1. Oral

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Injectable

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Topical

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Ocular

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Pulmonary

9.1.5.1. Market Revenue and Forecast (2019-2030)

9.1.6. Implantable

9.1.6.1. Market Revenue and Forecast (2019-2030)

9.1.7. Transmucosal

9.1.7.1. Market Revenue and Forecast (2019-2030)

9.1.8. Nasal

9.1.8.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Topical Drug Delivery Market, By Application 

10.1. Topical Drug Delivery Market, by Application, 2021-2030

10.1.1. Infectious Diseases

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Cancer

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Cardiovascular Diseases

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Diabetes

10.1.4.1. Market Revenue and Forecast (2019-2030)

10.1.5. Respiratory Diseases

10.1.5.1. Market Revenue and Forecast (2019-2030)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Topical Drug Delivery Market, By End User 

11.1. Topical Drug Delivery Market, by End User, 2021-2030

11.1.1. Home Care Settings

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Hospitals & Clinics

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Burn Centers

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Topical Drug Delivery Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.1.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.4. Market Revenue and Forecast, by End User (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.5.4. Market Revenue and Forecast, by End User (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.6.4. Market Revenue and Forecast, by End User (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.2.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.4. Market Revenue and Forecast, by End User (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.5.4. Market Revenue and Forecast, by End User (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.6.4. Market Revenue and Forecast, by End User (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.7.4. Market Revenue and Forecast, by End User (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.8.4. Market Revenue and Forecast, by End User (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.3.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.4. Market Revenue and Forecast, by End User (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.5.4. Market Revenue and Forecast, by End User (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.6.4. Market Revenue and Forecast, by End User (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.7.4. Market Revenue and Forecast, by End User (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.8.4. Market Revenue and Forecast, by End User (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.4.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.4. Market Revenue and Forecast, by End User (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.5.4. Market Revenue and Forecast, by End User (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.6.4. Market Revenue and Forecast, by End User (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.7.4. Market Revenue and Forecast, by End User (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.8.4. Market Revenue and Forecast, by End User (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.4. Market Revenue and Forecast, by End User (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.5.4. Market Revenue and Forecast, by End User (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.6.4. Market Revenue and Forecast, by End User (2019-2030)

Chapter 13. Company Profiles

13.1. Johnson & Johnson

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Novartis International AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. F. Hoffmann-La Roche AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Pfizer Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Bayer AG

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Antares Pharma, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. GlaxoSmithKline plc

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. 3M (US), Merck & Co., Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Sanofi

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Amgen, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments